Table 1. Clinical characteristics, heart failure risk factors, and echocardiographic measurements in the OxVALVE subset
CharacteristicTotal cohort, n (%)a,b
Participants277 (100)
Age, years, median (IQR)73 (68–78)
Sex
 Male152 (54.9)
 Female125 (45.1)
Ethnic group
 White269 (97.1)
 Asian5 (1.8)
 Black2 (0.7)
 Mixed1 (0.4)
Smoking status
 Non-smoker133 (48.0)
 Ex-smoker136 (49.1)
 Current8 (2.9)
BMI, kg/m2, median (IQR)27.6 (24.5–30.4)
Asthma20 (7.2)
COPD16 (5.8)
Inhaled steroids12 (4.3)
Atrial fibrillation39 (14.1)
Diabetes38 (13.7)
Hyperlipidaemia134 (48.4)
Hypertension149 (53.8)
Myocardial infarct12 (4.3)
PCI11 (4.0)
CABG5 (1.8)
Chronic kidney disease35 (12.6)
NYHA class
 I178 (64.3)
 II89 (32.1)
 III10 (3.6)
Socioeconomic class
 1 (least deprived)67 (24.2)
 265 (23.5)
 385 (30.7)
 436 (13.0)
 5 (most deprived)21 (7.6)
 Missing3 (1.1)
Ejection fraction, %, median (IQR)69 (66–73)
E velocity, median (IQR)0.60 (0.51–0.71)
Septal e’ velocity, median (IQR)0.05 (0.04–0.07)
E/e’, median (IQR)10.7 (9.1–13.5)
FeNO, ppb, mean (SD)24.2 (15.6)
  • aFeNO measurement was unsuccessful in 50 participants — these participants' data are included in all variables outside of FeNO. bUnless otherwise stated. BMI = body mass index. CABG = coronary artery bypass grafting. COPD = chronic obstructive pulmonary disease. FeNO = fractional exhaled nitric oxide. NYHA = New York Heart Association. PCI = percutaneous coronary intervention. ppb = parts per billion.